Lyra Therapeutics, Inc. (LYRA)
OTCMKTS · Delayed Price · Currency is USD
0.6500
-0.0500 (-7.14%)
At close: May 18, 2026
Lyra Therapeutics Market Cap
Lyra Therapeutics has a market cap or net worth of $1.15 million as of May 19, 2026. Its market cap has decreased by -84.29% in one year.
Market Cap
1.15M
Enterprise Value
15.52M
Revenue
398.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.65
Market Cap Chart
Since May 1, 2020, Lyra Therapeutics's market cap has decreased from 230.14M to 1.15M, a decrease of -99.50%. That is a compound annual growth rate of -58.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 1.24M | -77.27% |
| Dec 31, 2025 | 5.47M | -59.54% |
| Dec 31, 2024 | 13.51M | -95.09% |
| Dec 29, 2023 | 275.43M | 175.60% |
| Dec 30, 2022 | 99.94M | 76.26% |
| Dec 31, 2021 | 56.70M | -61.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 1, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LakeShore Biopharma | 1.60M |
| ZyVersa Therapeutics | 1.58M |
| Agentix | 1.52M |
| inTerra Resources | 1.47M |
| International Stem Cell | 1.42M |
| Abpro Holdings | 1.21M |
| Neon Bloom | 1.21M |
| Protagenic Therapeutics | 1.18M |